Clinical Trials Directory

Trials / Completed

CompletedNCT03682237

Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash Study

Optimizing Metabolic Control in Type 1 Diabetes With Multiple Daily Insulin Injections - Flash Glucose Monitoring, Carbohydrate Counting With Automated Bolus Calculation, or Both?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
184 (actual)
Sponsor
Steno Diabetes Center Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the effect of flash glucose monitoring (FGM) with traditional self-monitoring of blood glucose (SMBG) with or without carbohydrate counting and automated bolus calculation, in patients with type 1 diabetes and poor metabolic control. The investigators will include in total 200 patients recruited from 5 clinical sites in the Capital Region of Copenhagen. The patients will be randomized into four groups; A) Standard diabetes training, i.e. group training in in general diabetes health issues, B) Group training in carbohydrate counting and automated bolus calculation, the app MySugr will be taught and downloaded, C) Group training as in group A, and instructed to use FGM, D) Group training as in group B, and besides training in the use of the app MySugr, also instructed to use FGM. All patients are followed for 26 weeks with 6 clinical visits, group training (1 visit) and 2 telephone consultations. The primary outcome is time spent in normoglycemia.

Conditions

Interventions

TypeNameDescription
DEVICECarbohydrate counting, automated bolus calculationGroup training in carbohydrate counting and bolus calculation. The app MySugr will be taught and downloaded on own smart phone and person specific parameters will be estimated and entered in the app with the patients. SMBG measures at least 4 times daily with patients own preferred glucose meter.
DEVICEFlash glucose monitoring (FGM)Group training, patients will be instructed to use unblinded FGM for the whole study period. Patients are recommended to measure SMBG according to FGM manufactures guideline and handling of trend arrows etc.

Timeline

Start date
2018-10-01
Primary completion
2020-10-26
Completion
2020-10-26
First posted
2018-09-24
Last updated
2020-10-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03682237. Inclusion in this directory is not an endorsement.